Zenodo (CERN)
open access
CC BY 4.0
A druggable ATP13A3–antizyme switch controls adaptive polyamine uptake in cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Therapeutic targeting of SETD2-deficient cancer cells with the small-molecule compound RITA#4998
- INSM1 Regulates Neuroendocrine Plasticity and Tumor Progression in Prostate Cancer#610862
- Bottom-Up Programming of Cell States in Cancer Organoids with Defined Synthetic Adhesion Cues.#186019
- PRMT3 in cancer: arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance.#199153
- Avelumab in G2-3 NET#1137499
Record · ID 397834
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive